India Markets open in 2 mins.

Parenteral Drugs (India) Limited (PARENTLD.BO)


BSE - BSE Real Time Price. Currency in INR
Add to watchlist
22.65-0.55 (-2.37%)
At close: 3:02PM IST
Full screen
Previous close23.20
Open24.30
Bid22.25 x
Ask24.40 x
Day's range22.25 - 24.30
52-week range19.15 - 36.90
Volume7,631
Avg. volume11,754
Market cap675.34M
BetaN/A
PE ratio (TTM)-0.58
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Capital Cube4 months ago

    Parenteral Drugs (India) Ltd. :524689-IN: Earnings Analysis: Q3, 2017 By the Numbers : February 21, 2017

    Categories: Yahoo Finance Get free summary analysis Parenteral Drugs (India) Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Parenteral Drugs (India) Ltd. – Morepen Laboratories Limited, Jubilant Life Sciences Limited, Kopran Limited, Smruthi Organics Ltd and NATCO Pharma Limited (500288-IN, 530019-IN, 524280-IN, 590046-IN and 524816-IN) ... Read more (Read more...)

  • Parenteral Drugs (India) Ltd. Earnings Analysis: Q3, 2016 By the Numbers
    Capital Cubelast year

    Parenteral Drugs (India) Ltd. Earnings Analysis: Q3, 2016 By the Numbers

    Click here to see latest analysisParenteral Drugs (India) Ltd. reports financial results for the quarter ended December 31, 2015.We analyze the earnings along side the following peers of Parenteral Drugs (India) Ltd. – Morepen Laboratories Limited, Jubilant Life Sciences Limited, Kopran Limited, Smruthi Organics Ltd and NATCO Pharma Limited (500288-IN, 530019-IN, 524280-IN, 590046-IN and 524816-IN) […] (Read more...) The post Parenteral Drugs (India) Ltd. Earnings Analysis: Q3, 2016 By the Numbers appeared first on CapitalCube.

  • Parenteral Drugs (India) Ltd. Earnings Q1, 2015
    Capital Cube2 years ago

    Parenteral Drugs (India) Ltd. Earnings Q1, 2015

    Parenteral Drugs (India) Ltd. reports preliminary financial results for the quarter ended June 30, 2015.We analyze the earnings along side the following peers of Parenteral Drugs (India) Limited – Morepen Laboratories Limited, Jubilant Life Sciences Limited, Kopran Limited, Smruthi Organics Ltd and NATCO Pharma Limited (500288-IN, 530019-IN, 524280-IN, 590046-IN and 524816-IN) that have also reported (Read more...) The post Parenteral Drugs (India) Ltd. Earnings Q1, 2015 appeared first on CapitalCube.